PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Spideyboy]

It seems you have missed on the most important upcoming milestone then.

Full Phase III Bridge data due within 1Q2020 and I believe by end-Feb 2020. This will essentially prove if PRX-102 is in fact better than the current ERTs. While Bridge is using prior Replagal patients, essentially Replagal and Fabrazyme are the same product but just different forms of the same enzyme, alpha and beta respectively.

This IS THE MILESTONE. If that data is poor then all this goes down significantly, if the data does well then we go much higher I suspect.

Thus this most important milestone happens potentially with the next 7-8 weeks I believe. I do hope you are watching the company properly.

Thus definitely by end-March we have the Bridge data and if positive we go up, then BLA submission in April we again go up.

While money is still a question, I suspect if they do dilute this will happen post-Bridge data, as if the data is good and we do go up significantly that would be the best time. Even better if they wait till BLA filing, but with cash to take them to June, then waiting to April with their relatively high cash burn is pushing it.